A 3-Week, Open Label Study to Evaluate the Efficacy and Safety of Extended Release Quetiapine Fumarate in the Treatment of Agitation in Patients with Schizophrenia
Objective: To evaluate the efficacy of extended-release quetiapine fumarate (XR) monotherapy once daily, in the treatment of patients with acute episodes of schizophrenia and agitation. Method: Our study was a 3-week open-label study conducted in adult in- or outpatients with schizophrenia. Quetia...
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Taylor & Francis
2013
|
| Assuntos: | |
| Acesso em linha: | http://eprints.um.edu.my/9622/1/00000797_93562.pdf |